The Pulmonary Vascular Research Institute

🌏 We’re delighted to share that the PVRI Southeast Asia Task Force was relaunched in September 2026 The Task Force, co-led by Dr Suree Sompradeekul (Thailand) and Dr Ruan Wen (Singapore), aims to: 🔹 Strengthen collaboration and knowledge-sharing across Southeast Asia’s PH community 🔹 Identify regional priorities to improve PH diagnosis, treatment, and patient outcomes 🔹 Advance regional and national guidelines, registries, and data-sharing 🔹 Build a lasting regional network beyond PVRI 2027 in Bangkok Learn more about the Task Force’s relaunch, activities, and future plans: pvrinstitute.org/learning-hu… #PulmonaryHypertension #PH #SoutheastAsia

Missed our October Community Call? Our latest Community Call is now available on demand! Featuring Tyler Couch, Agustin Garcia and Olympia Bikou, the session explored the following: 🔹 Pulmonary artery dilation on chest CT Across the spectrum of chronic lung disease 🔹 CT imaging derived pulmonary vascular abnormalities associated with PH in chronic lung disease 🔹 MicroRNA-224 as a therapeutic target in preclinical pulmonary arterial hypertension ▶️ Watch the session now: pvrinstitute.org/learning-hu… #PulmonaryHypertension #PHResearch

New webinar series launch! 🎉 Women's Health Career Pathways: Jessica Badlam 📅 19 November 2026 🕓️ 16:00 GMT The Women's Health Task Force have launched their new series, 'Women's Health Career Pathways', that explores the personal and professional journeys of leaders working across women's health and PH. Join Jessica Badlam for the inaugural webinar. Through an in-depth conversation, Jessica will share the experiences, decisions, collaborations, and lessons that have shaped her career in women's health and PH research. ➡️ Register today: pvrinstitute.org/learning-hu…

Speaker spotlight💡 PVRI 2027 Bangkok will explore some of the biggest clinical and scientific challenges facing the PH community today, from critical care and Group 2 PH to advanced imaging and right ventricular recovery. Here’s a glimpse of what’s to come ⬇️ Multiomics Profiling to Uncover Mechanisms of PVD 🎙 Anna Hemnes, Vanderbilt University Medical Center Digital Twins in PAH: Integrating Multimodal Data for Precision Personalised Prognosis 🎙 Tiffany Baptiste, King's College London Redefining the Hemodynamics of PAH in the Sotatercept Era 🎙 Yogesh Reddy, Mayo Clinic Challenges in Classification, Evaluation, and Care of Pediatric Group 2 PH 🎙 Karin Tran-Lundmark, Lund University and Skåne University Hospital Balancing Risk & Clinical Outcomes During Pregnancy with PH 🎙 Jenna Skowronski, University of North Carolina PVRI 2027 Bangkok Bridging Science, Innovation & Care for the Next 20 Years 📅 27-31 January 2027 📍 Amari Bangkok Hotel & Conference Centre 🎟 Register now: pvrinstitute.org/learning-hu…

Last chance to nominate 🚨 Nominations for the PVRI Achievement Awards 2026 and PVRI President 2028-30 close tomorrow. ❓️Who has inspired you? ❓️Who has made an exceptional contribution to PH research or patient care? Now is your opportunity to recognise their impact. ➡️ Submit a nomination: pvrinstitute.org/learning-hu… 📅 Deadline: 28 October 2026 at 09:00 GMT

📊 What happens after a clinical trial ends? Many people have questions about study results, follow-up care, and how their personal information is protected. In this video from our 'Understanding clinical trials' PH patient resource collection, Luz Osorio from Sociedad Latina de Hipertensión Pulmonar discusses what patients can expect once a trial is complete. 🎥 Watch now: pvrinstitute.org/PH-patient-…

Nominations for PVRI President 2028-30 and PVRI Achievement Awards 2026 close next week ⏳️ PVRI members can: ▪️recognise outstanding contributions to PH research, care, collaboration ▪️shape the future leadership of PVRI We particularly encourage nominations that reflect the diversity and international nature of our community. 📅 Nominations close 28 October 2026 at 09:00 GMT ➡️ Submit a nomination: pvrinstitute.org/learning-hu…

Upcoming webinar 💻️ Bleeding ponies, bloated cattle and breathless mountaineers: hearts and lungs under duress with hypoxia and exercise 📅 17 November 2026 🕐️ 13:00 GMT In this webinar, Erik Swenson will explore how humans and animals respond to the challenges of hypoxia and exercise, drawing on decades of research in high-altitude medicine, respiratory physiology and extreme environments. ➡️ Register now: pvrinstitute.org/learning-hu…

Supporting early-career professionals and colleagues from LMICs 🌍🤝 We're committed to making the global PH community more accessible, inclusive and connected. PVRI 2027 Bangkok includes more support than ever for early-career professionals and colleagues from low- and middle-income countries (LMICs), including: ✅ reduced PVRI membership fees from just $15 per year ✅ reduced Congress registration rates ✅ travel awards helping early-career and LMIC delegates attend PVRI 2027 Bangkok ✅ seven Early Career Abstract Awards worth £2,000 each ✅ Career Catalyst PH Luncheon, providing mentoring from PH experts ✅ World Café PH Luncheon, to discuss challenges, and solutions for improving PH care globally ➡️ Find out more about PVRI 2027 Bangkok: pvrinstitute.org/learning-hu…

What can 4,000 patient voices tell us about PH? 💬 The PHGPS Dashboard helps you explore findings from nearly 4,000 patients and carers across 90 countries. Use the dashboard to: ▪️explore results by region ▪️compare diagnosis classifications ▪️filter by respondent type and gender ❓️ Want to dive deeper? You can also request access to the full PHGPS dataset to support: ✅️ research projects ✅️ advocacy initiatives ✅️ education programmes ✅️ service improvement 🔗 Explore the dashboard and request data access: pvrinstitute.org/learning-re…

📢 Join tomorrow's PH Community Call, 22 October 2026, 15:00 BST, to discuss: 🔹 Pulmonary artery dilation across chronic lung disease with Tyler Couch 🔹 CT imaging-derived pulmonary vascular abnormalities associated with PH with Agustin Garcia 🔹 A promising new therapeutic target in preclinical PAH involving microRNA-224 with Olympia Bikou Free and open to all. Register today pvrinstitute.org/learning-hu… #PulmonaryHypertension #PHResearch #PVRI

📅 What is it really like to take part in a clinical trial? From study visits and appointments to monitoring and health checks, participation can look different from person to person. In this video from our 'Understanding clinical trials' PH patient resource collection, Colleen Brunetti, explores some of the practical aspects of taking part in a clinical trial. 🎥 Watch now: pvrinstitute.org/PH-patient-…

A major milestone for #PulmonaryHypertension (PH) care in Sri Lanka. 🇱🇰 The country’s first Joint Clinical Statement on the medical management of #PH has been published and presented at the Sri Lanka College of Cardiology Annual Academic Sessions 2026. It was a collaborative effort between PVRI members of the Sri Lanka College of Cardiology, the Sri Lanka College of Pulmonology, and experts from the UK. The initiative reflects the growing commitment of clinicians, researchers and healthcare leaders in Sri Lanka and beyond to improving the diagnosis, management and long-term care of people living with PH in the country. Congratulations to everyone who contributed to this landmark achievement. 🔗 Read the Joint Clinical Statement and learn more about our Sri Lanka Task Force: pvrinstitute.org/srilanka #SriLanka #GlobalHealth #Cardiology

Every breakthrough in PH starts with people coming together globally to make progress possible 🌍🤝 Your donation helps PVRI: ▪️advance PH research worldwide ▪️support education and knowledge sharing ▪️connect researchers, clinicians and patients ▪️improve outcomes for people living with PH Together, we're building a future with better treatments, earlier diagnosis and improved care. 💜 Donate today: pvrinstitute.org/support-us

📢 Join the next PVRI PH Community Call on 🗓 22 October 2026, 15:00 BST 📢 Every month, researchers from around the world present their papers, and we discuss the latest advances in pulmonary hypertension. This month we explore: 🔹 Pulmonary artery dilation across chronic lung disease 🔹 CT imaging-derived pulmonary vascular abnormalities associated with PH 🔹 A promising new therapeutic target in preclinical PAH involving microRNA-224 Calls are free and open to all. Register today pvrinstitute.org/learning-hu… #PulmonaryHypertension #PHResearch #MedicalResearch #RespiratoryMedicine #PVRI #ScientificCommunity #CardiopulmonaryResearch

📢 Just one week to go! 8th International Leh Symposium 2026 📍 McLeod Ganj, Dharamshala, India 🗓 23-27 October 2026 Join the global PH community to explore the latest research on therapeutic targets and molecular mechanisms for pulmonary diseases in hypoxia. Highlights include: ▪️cutting-edge science in hypoxia and pulmonary disease ▪️international experts in research and clinical care ▪️opportunities for collaboration and scientific exchange ▪️discussions on advancing prevention and treatment strategies ➡️ Register here: lehsymposium.in/

⚙️ Randomisation? Placebos? Study design? Clinical trials use carefully designed methods to help researchers generate reliable results and understand whether new treatments are safe and effective. In this video from our 'Understanding clinical trials' collection, Jamie Myrah from PHA Canada explains some of the key concepts behind clinical trial design in an easy-to-understand way. 🎥 Watch the full series: pvrinstitute.org/PH-patient-…

Who do you think would make an excellent PVRI President? 🏆💡 Nominations are open for two more weeks for PVRI President 2028-30 and for PVRI Achievement Awards 2026. Help us celebrate the people shaping PH research, care & collaboration around the world. ➡️ Nominate: pvrinstitute.org/learning-hu… Nominations close: 28 October, 09:00 GMT

New research in Pulmonary Circulation 🫁 Validation of Tricuspid Annular Displacement by Tissue Doppler in Pulmonary Hypertension 📆 11 September 2026 🔢 16(3), e70372 👤 Rongrong Chen, Shadi P. Bagherzadeh, Neev Patel, Patrick Khoury, Bettia E. Celestin, Frida N. Hermansson, Jennifer P. Woo, Francois Haddad ➡️ Read the full research article: doi.org/10.1002/pul2.70372

What can blood biomarkers tell us about PAH? 🩸 Blood Biomarkers in Pulmonary Arterial Hypertension – New Insights 📅 12 November 2026 🕓️ 16:00 - 17:00 GMT You'll hear the latest research on: ▪️biomarker validation for clinical use ▪️plasma proteome risk stratification ▪️NOTCH3-ECD as a biomarker for PAH ▪️novel predictors of outcomes in PAH ▪️markers of vascular dysfunction ➡️ Register now: pvrinstitute.org/learning-hu…